To access this element change to forms mode OFF
Grant Award View - GA201533
Inflammasome inhibitors as new first-in-class anti-inflammatory...
GA ID:
GA201533
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
19-Aug-2021
Publish Date:
10-Nov-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$2,872,570.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Inflammasome inhibitors as new first-in-class anti-inflammatory therapies
Purpose:
Inflammation drives many devastating human diseases, and there are currently no effective treatments for many such diseases. My research program aims to leverage my validated discovery and development pipeline to deliver new first-in-class anti-inflammatory drugs to treat devastating diseases such as chronic liver disease and inflammatory bowel disease.
GO ID:
GO Title:
Investigator Grants 2021
Internal Reference ID:
2021/GNT2009075
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The University of Queensland
Recipient ABN:
63 942 912 684
Grant Recipient Location
Suburb:
St Lucia
Town/City:
St Lucia
Postcode:
4072
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
QLD
Postcode:
Country:
AUSTRALIA